Terlipressin versus norepinephrine as infusion in patients with septic shock: a multicentre, randomised, double-blinded trial
Terlipressin versus norepinephrine as infusion in patients with septic shock: a multicentre, randomised, double-blinded trial is a paper indexed in ScholarIQ from OpenAlex.
How many citations does Terlipressin versus norepinephrine as infusion in patients with septic shock: a multicentre, randomised, double-blinded trial have?
Terlipressin versus norepinephrine as infusion in patients with septic shock: a multicentre, randomised, double-blinded trial has 129 citations in the OpenAlex counts ScholarIQ stores.
When was Terlipressin versus norepinephrine as infusion in patients with septic shock: a multicentre, randomised, double-blinded trial published?
Terlipressin versus norepinephrine as infusion in patients with septic shock: a multicentre, randomised, double-blinded trial has 2018 year in the ScholarIQ index.
What is the open-access status of Terlipressin versus norepinephrine as infusion in patients with septic shock: a multicentre, randomised, double-blinded trial?
Terlipressin versus norepinephrine as infusion in patients with septic shock: a multicentre, randomised, double-blinded trial has closed oa status in the ScholarIQ index.
What is the DOI of Terlipressin versus norepinephrine as infusion in patients with septic shock: a multicentre, randomised, double-blinded trial?
The DOI for Terlipressin versus norepinephrine as infusion in patients with septic shock: a multicentre, randomised, double-blinded trial is on the source record.
What is the PMID of Terlipressin versus norepinephrine as infusion in patients with septic shock: a multicentre, randomised, double-blinded trial?
The PMID for Terlipressin versus norepinephrine as infusion in patients with septic shock: a multicentre, randomised, double-blinded trial is on the source record.
What is the OpenAlex record for Terlipressin versus norepinephrine as infusion in patients with septic shock: a multicentre, randomised, double-blinded trial?
The OpenAlex for Terlipressin versus norepinephrine as infusion in patients with septic shock: a multicentre, randomised, double-blinded trial is on the source record.